Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 0480-3685

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate (NDC 0480-3685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-01.jpg (Image 1)

Figure-01.jpg (Image 1)
Not available*
FDA Label Image

Figure-02.jpg (Image 2)

Figure-02.jpg (Image 2)
FDA Label Image

Label 12.5 mg (Image 3)

Label 12.5 mg (Image 3)
This is a description of a medication with the National Drug Code (NDC) 0480-3683-01. It is an extended-release capsule containing dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. Each capsule contains a total of 7.8 mg of amphetamine base equivalence. The recommended dosage is one capsule taken once daily in the morning. The medication should be stored at a temperature between 20°C and 25°C (68°F to 77°F) and kept in a child-resistant container. The medication guide should be provided to each patient by the pharmacist. This medication should not be substituted for Adderall XR.*
FDA Label Image

Label 25 mg (Image 4)

Label 25 mg (Image 4)
This text appears to be a description of a medication called Dextroamphetamine. It is an extended-release capsule that contains a combination of different salts of amphetamine. The medication is intended for once-daily use and should not be substituted for Adderall XR®. It is available as a prescription-only medication in a bottle containing 100 capsules. Each capsule contains specific amounts of dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. The total amphetamine base equivalence in each capsule is 15.6 mg. The usual dosage is one capsule taken once daily in the morning. The medication should be stored at a temperature of 20° to 25°C (68° to 77°F) and kept in a tightly sealed container with a child-resistant closure. The text also mentions the manufacturer of the medication, Teva Pharmaceuticals.*
FDA Label Image

Label 37.5 mg (Image 5)

Label 37.5 mg (Image 5)
This is a description of a medication called Dextroamphetamine Extended-Release Capsules. Each capsule contains dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. This medication is used to treat certain conditions and should not be substituted for Adderall XR. It is available in a pack of 100 capsules manufactured by Teva Pharmaceuticals. The usual dosage is one capsule taken once daily in the morning. It should be stored at a temperature between 20° to 25°C (68°to 77°F) and kept in a tightly sealed container. Please consult with a pharmacist for further instructions and refer to the accompanying Medication Guide.*
FDA Label Image

Label 50 mg (Image 6)

Label 50 mg (Image 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.